421 related articles for article (PubMed ID: 23023009)
1. Ten-year outcomes of percutaneous radiofrequency ablation as first-line therapy of early hepatocellular carcinoma: analysis of prognostic factors.
Kim YS; Lim HK; Rhim H; Lee MW; Choi D; Lee WJ; Paik SW; Koh KC; Lee JH; Choi MS; Gwak GY; Yoo BC
J Hepatol; 2013 Jan; 58(1):89-97. PubMed ID: 23023009
[TBL] [Abstract][Full Text] [Related]
2. Percutaneous radiofrequency ablation as first-line treatment for small hepatocellular carcinoma: results and prognostic factors on long-term follow up.
Waki K; Aikata H; Katamura Y; Kawaoka T; Takaki S; Hiramatsu A; Takahashi S; Toyota N; Ito K; Chayama K
J Gastroenterol Hepatol; 2010 Mar; 25(3):597-604. PubMed ID: 20074153
[TBL] [Abstract][Full Text] [Related]
3. Repeat radiofrequency ablation provides survival benefit in patients with intrahepatic distant recurrence of hepatocellular carcinoma.
Okuwaki Y; Nakazawa T; Kokubu S; Hidaka H; Tanaka Y; Takada J; Watanabe M; Shibuya A; Minamino T; Saigenji K
Am J Gastroenterol; 2009 Nov; 104(11):2747-53. PubMed ID: 19603009
[TBL] [Abstract][Full Text] [Related]
4. Younger hepatocellular carcinoma patients have better prognosis after percutaneous radiofrequency ablation therapy.
Kao WY; Chiou YY; Hung HH; Su CW; Chou YH; Huo TI; Huang YH; Wu WC; Lin HC; Lee SD; Wu JC
J Clin Gastroenterol; 2012 Jan; 46(1):62-70. PubMed ID: 21934530
[TBL] [Abstract][Full Text] [Related]
5. Post-recurrence survival in hepatocellular carcinoma after percutaneous radiofrequency ablation.
Facciorusso A; Del Prete V; Antonino M; Crucinio N; Neve V; Di Leo A; Carr BI; Barone M
Dig Liver Dis; 2014 Nov; 46(11):1014-9. PubMed ID: 25085684
[TBL] [Abstract][Full Text] [Related]
6. Radiofrequency ablation of hepatocellular carcinoma as first-line treatment: long-term results and prognostic factors in 162 patients with cirrhosis.
Lee DH; Lee JM; Lee JY; Kim SH; Yoon JH; Kim YJ; Han JK; Choi BI
Radiology; 2014 Mar; 270(3):900-9. PubMed ID: 24475823
[TBL] [Abstract][Full Text] [Related]
7. Percutaneous ablative therapies of recurrent hepatocellular carcinoma after hepatectomy: proposal of a prognostic model.
Yin XY; Xie XY; Lu MD; Kuang M; Liu GJ; Xu ZF; Xu HX; Wang Z
Ann Surg Oncol; 2012 Dec; 19(13):4300-6. PubMed ID: 22766980
[TBL] [Abstract][Full Text] [Related]
8. Initial treatment response is essential to improve survival in patients with hepatocellular carcinoma who underwent curative radiofrequency ablation therapy.
Takahashi S; Kudo M; Chung H; Inoue T; Ishikawa E; Kitai S; Tatsumi C; Ueda T; Minami Y; Ueshima K; Haji S
Oncology; 2007; 72 Suppl 1():98-103. PubMed ID: 18087189
[TBL] [Abstract][Full Text] [Related]
9. [Effect and prognostic analysis of radiofrequency ablation in treating advanced hepatocellular carcinoma].
Wu J; Chen MH; Yan K; Wu W; Yang W
Zhonghua Yi Xue Za Zhi; 2012 Mar; 92(11):735-8. PubMed ID: 22781351
[TBL] [Abstract][Full Text] [Related]
10. [Efficacy of radiofrequency ablation to treat advanced hepatocellular carcinoma].
Wu J; Chen MH; Yang W; Wu W; Yan K
Zhonghua Gan Zang Bing Za Zhi; 2012 Apr; 20(4):256-60. PubMed ID: 22964144
[TBL] [Abstract][Full Text] [Related]
11. Risk factors of survival after percutaneous radiofrequency ablation of hepatocellular carcinoma.
Peng ZW; Zhang YJ; Chen MS; Liang HH; Li JQ; Zhang YQ; Lau WY
Surg Oncol; 2008 Jul; 17(1):23-31. PubMed ID: 17869095
[TBL] [Abstract][Full Text] [Related]
12. Risk factors and prognostic factors of local recurrence after radiofrequency ablation of hepatocellular carcinoma.
Lam VW; Ng KK; Chok KS; Cheung TT; Yuen J; Tung H; Tso WK; Fan ST; Poon RT
J Am Coll Surg; 2008 Jul; 207(1):20-9. PubMed ID: 18589357
[TBL] [Abstract][Full Text] [Related]
13. Recurrence-free survival after radiofrequency ablation of hepatocellular carcinoma. A registry report of the impact of risk factors on outcome.
Zytoon AA; Ishii H; Murakami K; El-Kholy MR; Furuse J; El-Dorry A; El-Malah A
Jpn J Clin Oncol; 2007 Sep; 37(9):658-72. PubMed ID: 17766723
[TBL] [Abstract][Full Text] [Related]
14. Combination therapy with radiofrequency ablation and transcatheter chemoembolization for the treatment of hepatocellular carcinoma: Short-term recurrences and survival.
Yamakado K; Nakatsuka A; Akeboshi M; Shiraki K; Nakano T; Takeda K
Oncol Rep; 2004 Jan; 11(1):105-9. PubMed ID: 14654911
[TBL] [Abstract][Full Text] [Related]
15. Radiofrequency ablation for intrahepatic recurrent hepatocellular carcinoma: long-term results and prognostic factors in 168 patients with cirrhosis.
Lee DH; Lee JM; Lee JY; Kim SH; Han JK; Choi BI
Cardiovasc Intervent Radiol; 2014 Jun; 37(3):705-15. PubMed ID: 23912493
[TBL] [Abstract][Full Text] [Related]
16. Radiofrequency ablation of hepatocellular carcinoma in cirrhotic patients.
Guglielmi A; Ruzzenente A; Battocchia A; Tonon A; Fracastoro G; Cordiano C
Hepatogastroenterology; 2003; 50(50):480-4. PubMed ID: 12749252
[TBL] [Abstract][Full Text] [Related]
17. Prospective study of a 'popping' sound during percutaneous radiofrequency ablation for hepatocellular carcinoma.
Fernandes ML; Lin CC; Lin CJ; Chen WT; Lin SM
J Vasc Interv Radiol; 2010 Feb; 21(2):237-44. PubMed ID: 20031448
[TBL] [Abstract][Full Text] [Related]
18. Radiofrequency ablation: technical and clinical long-term outcomes for single hepatocellular carcinoma up to 30 mm.
Brunello F; Cantamessa A; Gaia S; Carucci P; Rolle E; Castiglione A; Ciccone G; Rizzetto M
Eur J Gastroenterol Hepatol; 2013 Jul; 25(7):842-9. PubMed ID: 23442417
[TBL] [Abstract][Full Text] [Related]
19. Intrahepatic recurrence after percutaneous radiofrequency ablation of hepatocellular carcinoma: analysis of the pattern and risk factors.
Kim YS; Rhim H; Cho OK; Koh BH; Kim Y
Eur J Radiol; 2006 Sep; 59(3):432-41. PubMed ID: 16690240
[TBL] [Abstract][Full Text] [Related]
20. Perivascular versus nonperivascular small HCC treated with percutaneous RF ablation: retrospective comparison of long-term therapeutic outcomes.
Kang TW; Lim HK; Lee MW; Kim YS; Choi D; Rhim H
Radiology; 2014 Mar; 270(3):888-99. PubMed ID: 24475820
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]